Your browser doesn't support javascript.
loading
Long-Term Follow Up of Patients with Mild-to-Moderate Alzheimer's Disease Treated with Bapineuzumab in a Phase III, Open-Label, Extension Study.
Salloway, Stephen P; Sperling, Reisa; Fox, Nick C; Sabbagh, Marwan N; Honig, Lawrence S; Porsteinsson, Anton P; Rofael, Hany; Ketter, Nzeera; Wang, Daniel; Liu, Enchi; Carr, Stephen; Black, Ronald S; Brashear, H Robert.
Afiliação
  • Salloway SP; Brown Medical School, Butler Hospital, Providence, RI, USA.
  • Sperling R; Center for Alzheimer Research and Treatment, Brigham and Women's Hospital, MA, USA.
  • Fox NC; Dementia Research Centre, University College London, Institute of Neurology, London, UK.
  • Sabbagh MN; Barrow Neurological Institute, Phoenix, AZ, USA.
  • Honig LS; Columbia University, New York, NY, USA.
  • Porsteinsson AP; University of Rochester School of Medicine and Dentistry, Rochester, NY, USA.
  • Rofael H; Janssen Alzheimer Immunotherapy Research & Development, LLC, South San Francisco, CA, USA.
  • Ketter N; Janssen Alzheimer Immunotherapy Research & Development, LLC, South San Francisco, CA, USA.
  • Wang D; Janssen Alzheimer Immunotherapy Research & Development, LLC, South San Francisco, CA, USA.
  • Liu E; Janssen Alzheimer Immunotherapy Research & Development, LLC, South San Francisco, CA, USA.
  • Carr S; Janssen Alzheimer Immunotherapy Research & Development, LLC, South San Francisco, CA, USA.
  • Black RS; Pfizer Inc, Collegeville, PA, USA.
  • Brashear HR; Janssen Research & Development LLC, Pennington, NJ, USA.
J Alzheimers Dis ; 64(3): 689-707, 2018.
Article em En | MEDLINE | ID: mdl-29914022
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Antipsicóticos / Doença de Alzheimer / Anticorpos Monoclonais Humanizados Idioma: En Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Antipsicóticos / Doença de Alzheimer / Anticorpos Monoclonais Humanizados Idioma: En Ano de publicação: 2018 Tipo de documento: Article